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Interstitial retinoid-binding protein (IRBP) is syn­
thesized and secreted by rod photoreceptor cells into 
the interphotoreceptor matrix and is known to bind 
retinoids and fatty acids. We have used cDNA clones 
encoding human IRBP to isolate a 15-kilobase genomic 
fragment that encompasses the complete human IRBP 
gene. The IRBP gene spans more than 11 kilobases 
and is interrupted by three introns, all of which are 
positioned near the 3 '-end of the coding sequence. The 
3 7 4 1 -base pair coding region of IRBP appears to have 
been generated by quadruplication of an approxi­
mately 900 base pair long ancestral gene. The deduced 
amino acid sequence predicts a mature protein of 1,230  
residues (calculated molecular weight 133,000). The 
protein sequence can be aligned into four homologous 
segments, each consisting of about 300 residues. Se­
quence similarity between segments is as high as 60% 
when conservative substitutions are taken into ac­
count. Two putative iV-linked glycosylation sites are 
located in highly conserved domains in the center of 
the first and second segment o f IRBP. A domain con­
sisting of 41 residues at the COOH-terminal end of the 
third segment has 15 matching residues (38%) with an 
intradiscal loop of rhodopsin, a retinal-binding protein 
in rod photoreceptors.
Vitamin A (retinol) is an essential component of the visual 
cycle in the vertebrate retina. The 11-cis conformer of vitamin 
A aldehyde (retinal) serves as a chromophor of the visual 
pigment rhodopsin in photoreceptor cells (1). After photore­
ception and bleaching, 11-cis retinal is regenerated extracel­
lularly in the pigment epithelium (2, 3). Regenerated retinal 
must be returned from the pigment epithelium to the photo­
receptors. Interstitial or interphotoreceptor retinoid-binding 
protein (IRBP)1 has been suggested to serve as a vehicle for 
transfer of retinoids (4-6). Bovine IRBP was shown to contain
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bound retinol, whose amount increased when eyes were illu­
minated prior to isolation of IRBP. Binding studies have 
shown that each mole of IRBP can bind 2 mol of all-trans 
retinol (7) with an association constant of 106 M-1. In addition 
to  all-trans retinol, bovine IRBP binds retinal, retinoic acid, 
cholesterol, fatty acids, and tocopherol indicating multiple 
functions for this complex protein. Recent studies (8) suggest 
tha t IRBP may function as a “buffer” protein for retinoids 
and may not participate actively in their transport.
IRBP is a large, soluble, single-subunit glycolipoprotein (9­
11). In humans, the molecular weight of mature, glycosylated 
IRBP has been determined by sodium dodecyl sulfate-poly- 
acrylamide gel electrophoresis to be approximately 135,000 
(12). In bovine, the molecular weight was shown to be 145,000 
(7). The shape of the molecule appears to be elongated, as 
judged by the relation of its Stokes’ radius to its molecular 
mass, its sedimentation properties (13), and by its appearance 
in electron-microscopical specimens (14).
Our goal is to understand the regulation of IRBP gene 
expression in mammalian photoreceptors, the structure and 
function of IRBP, and its possible involvement in retinal 
disorders. Evidence has been presented tha t rod photoreceptor 
cells synthesize and secrete IRBP into the interphotoreceptor 
matrix (15-17). IRBP is also expressed in cells tha t are not 
differentiated photoreceptors, such as mammalian pinealo- 
cytes (18), and transformed cells of human retinoblastoma 
(19, 20). Partial cDNA sequences for bovine and human IRBP 
have been described (21-23). Human IRBP cDNA sequences 
were used to map the gene to chromosome 10pll.2 —* q ll.2  
(23), and to identify two-allele BgU I (24), and Sty I (25) 
restriction fragment length polymorphisms. The Bglll restric­
tion fragment length polymorphism has established linkage 
between the multiple endocrine neoplasia, type 2a locus and 
the IRBP gene (26).
In this paper, we used human cDNA probes to isolate a 15­
kb genomic clone HGL-3 tha t contains the complete human 
IRBP gene. The gene structure including exon/intron ar­
rangement, transcription start site, and complete exon se­
quences are described. In addition, unusual features of the 
predicted IRBP peptide are discussed.
EXPERIMENTAL PROCEDURES
RNA Isolation and Analysis—Human eyes (Lion’s Eyes of Texas 
Eye Bank, Houston, TX) were dissected within 8 h post-mortem, the 
retinas and pigment epithelium-choroid were separately removed, 
frozen in liquid nitrogen, and stored in RNase-free microcentrifuge 
tubes. Total retina RNA was isolated by the extraction procedure of 
Chirgwin et al. (27). Polyadenylated RNA was selected by oligo(dT)- 
cellulose chromatography (28).
Isolation of cDNAs and Gene Fragments Encoding Human IR B P— 
Human IRBP cDNA clones H4 (American Type Culture Collection 
No. 59198) and H12 (Fig. 1) were isolated as described earlier (22) 























Nathans, The Johns Hopkins University). Both H4 and H12 had 
inverted complementary sequences at the 5 ' end due to cloning 
artifacts. These are 325 bp in H4 and 20 bp in H12. H20 and H18 
were isolated from a human retina cDNA library. The double­
stranded cDNA for this library was prepared according to  Gubler and 
Hoffman (29), ligated to £coRI linkers, and inserted into the unique 
EcoRl site of XgtlO (30). Both H18 and H20 were free of 5' artifacts. 
A human genomic library in EMBL3 was purchased from Clonetech, 
Palo Alto, CA. This library was screened with H4, H18, and H20 
cDNA probes, and three overlapping clones, each with 15-17-kb 
insertions, designated as HGL-1, HGL-2, and HGL-3, were isolated. 
HGL-3 was further characterized (Fig. 1) and shown to span the 
entire coding region.
DNA Isolation and Sequencing—Plasmid DNA was isolated in a 
small scale according to a modified procedure of Birnboim and Doly 
(31) and in a larger scale by cesium chloride density gradient centrif­
ugation (32). Bacteriophage X-DNA was isolated from confluent 
plates (33) or lytic cultures (32). Plasmid DNA was sequenced by the 
dideoxynucleotide chain termination method (34) using the cyclone 
method in M13 vectors (35) or the double-stranded sequencing 
method (36) in pucl9 vectors. Universal M13 and synthetic (Genetic 
Designs, Inc., Houston, TX) oligonucleotide primers (GL-1 to GL-
31, Fig. 2) were used to prime T7 DNA polymerase (“sequenase,” 
United States Biochemical Corp., Cleveland, OH).
Transcription Start Site—To determine the transcription start site, 
SI nuclease protection and primer extension experiments were carried 
out. For S i nuclease protection (37), an 822-bp Avail fragment of the 
genomic fragment S3 (Fig. 1) tha t spans the 5 ' end of IRBP mRNA 
was used. Briefly, the fragment was end-labeled with [7 -32P]ATP (Du 
Pont-New England Nuclear) and T4 polynucleotide kinase (Bethesda 
Research Laboratories). The denatured fragment was hybridized to 2 
jig of human retina poly(A) mRNA in 80% formamide, and the 
hybridization products digested with S i nuclease (Pharmacia LKB 
Biotechnology Inc). The size of the protected fragment was deter­
mined on an 8% polyacrylamide-urea sequencing gel adjacent to the 
sequencing ladder generated by priming denatured S3 fragment with 
an antisense primer, whose 5 ' end was identical with th a t of the 
A vail fragment. For primer extension (38), poly(A) mRNA (2 fig) and 
end-labeled antisense primers (Gl-1, Gl-2, Gl-3, and Gl-23, see Figs.
2 and 3) hybridizing to mRNA near AUG were annealed and extended 
by avian myeloblastosis virus reverse transcriptase (Promega Biotech, 
Madison, WI). The sizes of the extended fragments were determined 
as described above. In some primer extension experiments, dideoxy- 
nucleotides were added as chain terminators (39) and RNA sequences 
determined.
RESULTS AND DISCUSSION
Isolation and Characterization of Human IRBP Clones—We 
have used labeled H4, H18, and H20 cDNA inserts (see Fig.
1) to isolate three overlapping genomic clones (HGL-1 to 
HGL-3), one of which, HGL-3, contained the complete IRBP 
gene including transcription start site, all introns, and a 
putative polyadenylation signal. In addition to the IRBP gene 
sequences, HGL-3 contained flanking sequences tha t extend 
>2 kb upstream from the translation initiation codon and at 
least 450 bp downstream from the translation termination 
codon. To obtain a complete sequence of the exons, to map 
the exon/intron junctions, and to estimate the length of the 
introns, the 15-kb Sail insert of HGL-3 was digested with 
Pstl, Sstl, and .EcoRI generating a series of overlapping ge­
nomic fragments. The Pstl fragments P1-P13, the Sstl frag­
ments S2-S7, and the EcoRI fragments R1-R4 were subcloned 
into pUC vectors and completely or partially sequenced. The 
orientation of fragments, partial restriction maps, coding and 
flanking regions of the gene, and the distribution of introns 
and exons in the gene are illustrated in Fig. L4.
The 5' end of the gene, including transcription start site 
and translation initiator ATG, was contained in the 2.5-kb 
fragment S3. An 822-bp Avail 5' end-labeled subfragment of 
S3 was used for S i protection experiments to determine the 
transcription start site (see “Experimenal Procedures”). The 
1.3-kb genomic fragment S5 contained the end of exon 1, the 
junction of which was sequenced with an exon 1 specific
P7 P23
exon 3 exon 4
HT hi IV
Fig. 1. Map of hum an IR B P gene and it s  mRNA. A, restric­
tion map, orientation of genomic fragments, and distribution of 
introns and exons of the IRBP gene. The extent of fragments excised 
from the 15-kb genomic clone HGL-3 with Sstl (S2 -S7 ), EcoRl (R l-  
R4), and P stl (P1-P13) is indicated by bars. RP2 is an £coRI 
subfragment of P2. Symbols for restriction enzymes are P, Pstl-, S, 
Sstl; R, £coRI. The structure derived from sequence analysis of the 
fragments is illustrated as follows: the hatched boxes represent exons, 
the open boxes represent untranslated regions, and lines represent 
introns or flanking regions. The initiation codon, ATG, and the 
translation termination codon, TAG, are indicated below the boxes. 
B, structure of IRBP mRNA derived from cDNA clones. The quad­
ruplicated mRNA segments are depicted as I-IV , and the extent of 
the four overlapping cDNA fragments H20, H12, H4, and H18 is 
indicated by bars. The box 5 ' to the first quadruplicated segment 
represents sequences translated into a signal peptide. Scales in A  and 
B  are in kb.
primer {GL-10, see Fig. 2) and an antisense intron 1 primer 
located about 250 bp 3' of the junction (not shown). The 3.4­
kb fragment S2 harbored exon 2, the position of which was 
mapped with overlapping fragments R2, P2, and an .EcoRI 
subfragment of P2, termed RP2 (Fig. L4). The junctions of 
exon 2 were sequenced with exon 2-specific sense and anti­
sense primers (Fig. 2). Exon 3 was identified similarly in the 
genomic fragment R3 which overlaps with fragments S2 and 
S4. Fragments S4 and R1 carried the beginning of exon 4 and 
the translation stop codon. R l harbored both translation stop 
and a putative polyadenylation signal. All cDNA clones were 
5 '- and 3'-truncated but were overlapping and covered the 
complete coding sequence of IRBP (Fig. IB).
IRBP Gene Structure—The IRBP gene spans more than 11 
kb and is interrupted by three introns. Fig. 2 shows a 4290- 
bp composite sequence of the exons, constructed from over­
lapping sequences of cDNA and genomic clones, and a trans­
lated amino acid sequence. In addition to exon sequences, the 
positions and terminal 12 bases of introns are shown. Except 
for cloning artifacts at their 5 ' ends, cDNA sequences of 
clones H4, H12, H18, and H20 were consistent with exon 
sequences of genomic clones. Exon boundaries in genomic 
fragments were localized by alignment of sequences with those 
of cDNA clones. The large exon 1 extending from the tran ­
scription start site to the first intron junction consists of 3176 
bp. It contains more than three quarters of the structural 
gene. The central exons 2 and 3 are small (192 and 143 bp, 
respectively) and embedded in approximately 6 kb of intron 
sequences. The length of the three introns are estimated to 
be 2.1 kb (intron 1), 2.0 kb (intron 2), and 1.3 kb (intron 3) 
(Fig. 1). Exon 4 contains the COOH terminus of IRBP and a 
polyadenylation signal (see below). The exact length of exon

















8 2 0 2 Interstitial Retinoid-binding Protein
tctgggtcaaaccaccctggccactcctccccgatacccagggttgatgtgcttgaattagacaggattaaaggcttactggagctggaagccttgccccanctcaggagtttagcccc
^ --------------qL2---------------  --------------- G L23-------------------
-------------------CL1------------------------ ----------- GL3-----------------
1 ACACCTTCTCTCCACCACCTCACAAGGACAACGGCCGaACCCa GCTCCa CAGAGCa CCCCCACCGCCTTCCACACAGTCCa GCGAGCTTTTGTCCACCAGCCAGGCCTCCCCCTGGGTCCCC
1 2 3  a t g a t c a c a g a a t c g c t t c t c c t c a t g t c c c t g c t g c t c t g t g c c c t g g c t g g c c c c a c a c a c c t c t t c c a c c c a a g c c t g g t c c t g c a c a t g g c c a a c g t c c t c t t c g a t a a c t a c t g c
M M R E W V L L r t S V L L C G L A G P T H L F Q P S L V L D M A K V L L D N Y C  2 3  
- 1 7  + i
2 4 3  t t c c c g g a c a a c c t c c t g c g c a t c c a g g a a c c c a t c c a g c a g c c c a t c a a c a C c c a t g a c a t t c t g a g c a t c t c a g a c c c c c a c a c g c t g g c c a c t c t g c t g a c a c c c c c g c t g c a c a g c
F P E N L L G M Q E A I Q Q A I K S H E I L S I S D P Q T L A S V L T A C V Q S  G3
3 6 3  Tc CCTCAACCATCCTCCCCTCCTCATCTCCTATCACCCCAGCACCCCCCAGCCTCCCCCACAACTCCCACCACTCACCAGCCTCTCACAACAGCAACTCCTTGCCTGGCTCCAAACGCGC





------------------C L 2 5 ---------- ►
4 8 3  c t c c g c c a t g a g c t t c t c g a g c g i a a t g t g c c c t a c c t g c c c c t g g a c a c c c t c c c g c g c c a g g a c c t c c t c a g c a t g a t g c c c g a g t t c c t g c t c c c c c a c g t c t c c c g g a a t c t c a t g
L R H E V L E C N V C Y L R V D S V p G e E V L S M M C E F L V A ,  H V H C N L M  1 4 3
6 0 3  CCCACCTCCCCCTTACTGCTCCATCTCCCCCACTCCACACGACCCCACGTCTCTCCCATTCCCTACATCATCTCCTACCTGCACCCACGGAACACCATCCTCCACCTGGACACTATCTAC
C T S A L V L D L R H C T C C « ¥ S C I P y i I S y i H P C N T I l H V B I l y  1 8 3
7 2 3  a a c c c c c c c t c c a a c a c c a c c a c c g a c a t c t c c a c c t t c c c c c a c g t c c t c g c a g a a a c g t a c c c t c c c g a c a a g g a t c t c c t c g t c c t c a c c a c c a c c c a g a c c a g g c c c c t c c c c g a c
N R P S N T T T E I W T L P Q V L G E R Y C A D K D V V V L T S S O T R C V A E  2 2 3
8 4  3 GACATCCCCCACATCCTTAAGCACATGCCCAGCGCCATCGTCCrCCCCCACCGGACrCCCGCACGGCCCCTCCACCrCCGCAAGCTCAGGATACGCCAGTCTGACTICrTCTTCACCCTC
D I  A H 1 L K Q M B R A I V V G E S T G G G A L D L R K L R 1  G E S D F F F T V  2 6 3
9 6 3  c c c c t c t c c a g g t c c c t c g g g c c c c t t c g t g c a c c c a g c c a g a c g t g g c a c g g c a c c c g c c t c c t g c c c t g t c t g g g g a c t c c g g c c c a g c a g g c c c t g g a g a a a c c c c t g c c c a t c c t c
p v s r s l g p l c g c s q t w e c s g v l p c v g t p a e q a l e k a l a i l I 3 0 3
— C L 2 6 ------------
1 0 8 3  a c t c t g c g c a g c c c c c t t c c a c c c c i a g t c c a c t c c c t c c a c g a g g t c c t c a a g g a c t a c i a c a c g c t g g t g g a c c g t g t g c c c a c c c t c c t g c a g c a c t t g g c c a c c a t c g a c t t c i c c
T L R S A L P G V V H C L Q E V L K D Y Y T L V D R V P T L l . Q H l . A S M I > r S  3 4 3
1 2 0 3  ACGGTCGTCTCCGAGCAAGATCTGGTCACCAAGCTCAATGCCCCCCTCCACGCTCCCTCTCACCATCCCAGGCTCCTGGTGCCACCCATCGCGCCCACACAAACTCCTTCTTCCCCCCCC
T V V S E E D L V T K I N A C L Q A A S E D P R I L V R A I C P T E T P S V P A  3 8 3
1 3 2 3  CCCCACGCTCCAGCCGAACACTCACCAGGGCTGGCCCCAGACTTCCCTGACGACCa GGCTATCCGGCAACCACTGCTGCACTCTCTCTTCCAGCTGTCCGTGCTCCCACGCAATGTGGGC
P D A A A E D S P G V A P E L P E D E A I R Q A L V D S V f S i V S V L P C N V G  4 2 3
1
V  1 4 4 3  TACCTCCCCTTCCATa CTTTTCCTGACCCCTCCCTCCTGCGTCTGTTGCCCCCATa TCTCCTGCGCCACCTGTGGGACCCCCTACAGGACACGGAGCACCTCATCATGGACCTCCCCCAC
Y L R F D S F A D A S V L G V L A P Y V L R Q V W E P L Q D T E H L l r t D L f l H  4 6 3
P
1 5 6 3  AACCCTCGACCCCCATCCTCTCCTGTGCCCCTCCTCCTCTCCTACTTCCAGGCCCCTGACGCCGGCCCCCTCCACCTCTTCACCACCTATCATCCCCGCACCAACATCACGCACGAGCAC
N P G C P S S A V P L I - L S Y P O C P E A G P V K L r T T Y D R R T N I T O E H  5 0 3
1 6 8 3  TTCAGCCACATCGACCTCCCGGGCCCACGCTACACCACCCAACCTGGGCTGTATCTCCTCACCAGCCACCGCACCGCCACGGCCGCGGACGAGTTCGCCTTCCTTATGCACTCCCTGGCC
F S H M E L P C P R Y S T Q R G V Y L L T S H R T A T A A E E F A P l - M Q S L C  5 4 3
1 8 0 3  TGGGCCACACTGGTACGTCAGATCACCCCGGGCAACCTCCTGCACACCCGCACGCTCCCGCTGCTGCa CACACCCGAACCCAGCCTCGCGCTCACCGTGCCGGTCCTCACCTTCa TCGAC
K A T L V G E I I A G N X - L H T R I V P t L D T P E G S L A l T V P V t T r l D  5 8 3
1 9 2 3  AATCACGGCCACCCCTGCCTGGCTCCTGCACTGCTCCCCGATCCCATCCTCCTGCCCGACGACCCCCTGGACAAACCCCAGGAAGTCCTGGAGTTCCACCAAAGCCTGGGGCCCTTCGTG
N H G E A W L G G G V V P D A I V L A E E A I - D K A O E V l I e F M O S L G A L V  6 2 3
L. • 1 • ■
F ig . 2. Nucleotide sequence, predicted amino acid sequences, and intron/exon junctions of the hum an 
IRBP gene. Numbers on the left side indicate nucleotide positions starting with position 1, the transcription start 
site. Intron (IV S ) sequences are depicted in lowercase letters, only the first or last 12 nucleotides of each intron 
are shown. Synthetic primers used for DNA sequencing and primer extension experiments are overlined. The 
direction of primer extensions are indicated by arrows. Putative polyadenylation signals AATAAA in the 3 '- 
flanking sequence are underlined. Numbers on the right side indicate positions of amino acids starting with +1, 
the NHz-terminal glycine of the mature protein. Amino acids are depicted in single-letter symbols underneath their 
respective codons. The signal peptide is located at positions —17 to —1. Position 618 to the COOH-terminal end 
shows an alignment with published tryptic peptide sequences (marked by brackets) or amino acid sequences 
deducted from cDNA fragments of bovine IRBP (22, 23). Boundaries of the four homologous segments (see Figs.
1, 4, and 5) are indicated by vertical bars.
The 5' end of the IRBP gene was determined by the 
following two independent methods (Fig. 3); S i nuclease 
protection and extension of synthetic primers. In the Si 
nuclease mapping experiment, we annealed a 822-bp 5 ' end- 
labeled Avail fragment of S3, which is a 5 ' proximal genomic 
fragment of HGL-3, to poly(A) mRNA of the human retina 
and digested with SI nuclease. For priming cDNA synthesis, 
we selected a series of synthetic oligonucleotides 17-21 nucle­
otides in length, and complementary to mRNA near AUG. 
The primer GL-23 used for the extension experiment shown 
in Fig. 3 was selected to extend upstream from the Avail site. 
Its major extension product and the lower of the two major 
fragments protected by S i nuclease were of the same length . 
(Fig. 3, lanes 1 and 2). The results demonstrate tha t the major 
transcription start site is located at an adenine (position +1) 
















Interstitial Retinoid-binding Protein 8203
2 0 4 3  CACCGCACAGGGCACCTGCTGCAGCCCCACTATCCTCCGCCAGAGGTCCTGCGGCAGACCACTCCCCTCCTGCCGCCCAAGCTCCCCCACGCCCCCTACCGCACAGCTCTGCACTTGCAG
E C T C H L L E A H Y A R P E V V G Q T S A L L R A K L A O G A Y R T A V D L E  6 6 3
' ' ' • l ) L .............................................H G . .  .  J  L ..................J
2 1 6 3  TCTCTGCCCTCTCAGCTCACAGCAGACCTCCAGGACCTGTCTGCGGACCACCCCTTCCTAGTGTTCCACAGCCCTCGCCACCTGCTGGTACAGGAACCACCCCCACCACCCCCTGCTCTC
S L A S a t T A D i e E V S  G D H R L L V r H S P G E l V V E E A P P P P P A V  703
| ........................................................................M . A .................................................... O . V .
2 2 8 3  CCCTCTCCACAGCACCTCACCIACCTTATIGACGCCCTGITCAACACACACCTCCTGCCCGGCCACCIGGGCIACCIGCCTITTCACCCCATCCCTGAACTGGACACACTCAACCCCGTG
P S P E E L T Y L I E A L P K T E V L P G Q L C Y L R P D A M A E L E T V K A V  7 4 3  
.  . H . . .  H . Y . I  J  L'  '
2403 c c c c c a c a c c t c c t g c c c c t c g t a t c g c a a c a c c t g c t c c a c a c c c c t c c c c t g c t c a t c g a c c t c c c c t a c a a c c c t c c c a c c t a c t c c a c g g c c a t c c c g c t g c t c t c c t c c t a c t t c
C P O L V R L V V Q Q L V D T A A L V I D L R Y N P G S Y S T A I P L L C S Y E  7 8 3
...............• • • • • 5JL • • • _ _ CL8_ .v_ . t; J L .............................v .........................
2523 i i t g a g c c a c a g c c c c g c c a g c a c c t c i a t i c t c t c t t t c a c a c g g c c a c c t c a a a a c t c a c g c a g c t c i g c a c c t t c c c c c a c c t c g c c g g c c a c c c c t a c c c c i c a c a c a a g c a c c t c
F E A E P B Q H L Y S V P D R A T S K V T E V V T L P Q V A C Q R Y G S H K D L  8 2 3
......................J L ? .....................................J  L .................................H . r . . J
----------- G L31---------------------- ►
2 6 4 3  ia c a t c c t c a ig a c c c a c a c c a c ic g c ic t c c g g c c c a c c c c t t t g c a c a c a c c a t g c a g c a c c ic c a c c c g g c c a c g c ic a t t g c c c a c c c c a c c g c c g c a c g c g c a c t c t c t c t c c g c
Y I  L H S H T S G S A A E A F A H T M Q D L O R A T V I C E P T A G C A L S V G  8 6 3
L • .................................................
2 7 6 3  a t c t a c c a c c t c c c c a c c a c c c c c t t a t a t g c a t c c a t g c c c a c c c a g a t c g c c a t c a g t c c c a c c a c a g c c a a c c c c t c c c a c c t c c c t g c t c t g c a c c c c c a c a t c a c t c t g c c c a t c
l Y Q V C S S P L V A S M P T Q M A r t S A T T C K A W D L A C V E P D I T V P M  9 0 3
...................................................... A .  . . . I  I .  .  S .  .  E .............................................................................................................................
---------------GL 1 0 ------------- ►
2 8 8 3  a c c c a a c c c c t t t c c a t a c c c c a g g a c a t a c t c g c t c t c c g t c c c a a c c t c c c c a c c c t g c t g c a c a c g g c c g g c a a c c t g c t c c c t g a t a a c t a t g c c t c t g c c g a g c t c c g c g c c a a c
S E A L S I A 0 D I V | A L R A K V P T V L C T A G K L V A D N Y A S A E L C A K  9 4 3
• v • • • 1 J  L .................................p . . . v .
3 0 0 3  ATGGCCACCAAACTCAGCCCTCTCCAGACCCGCTACTCCACCGTCACCTCACAACIGCCCCTAGCCCACAICCIGGGCCCTCACCICCACATGCTCTCCCCAGACCCACACCTGAACGCA
H A T K L S G L O S R Y S R V T S E V A L A E I L G A D I . E t t L S G D P H I . K A  9 8 3  
. . A E ............................................................... A ...........................................A ....................................................0 . . . Q V ......................................................................T
IV S 1
3 1 2 2  GCCCATATCCCTGACAATCCCAAGGACCGCATTCCTCGAATTGTCCCCATGCAGgtgagacccaag........................ caactcttacagATCCCTTCCCCTGAAGTATTTGAACAGCTCATC
A H I P E N A K D R I P C I V P H Q  I P S P E V F E E L I  1 0 1 2  
.................................... D .........................................................................................................  ...............................................................D . .
-C L 1 8 --------- ►  ■*-----------G L 2 0 -
3 2 1 0  AACTTTICCTICCACACTAACCTCCTICAGGACAACATTGGCTACTTGAGCTTTCACATGTTTGCCGACGGTCAGCTCCTCACCCAGGTCTCCACCCTGCTGGTGGAGCACATCTGCAAC 
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. .  . . 8 P . . . . C . V . . . . I .............................................C .............................................................E ........................................... I V
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S '  IVS2
- S  3 3 3 0  AAGATCATCCACACCGATGCCATGATCATCGACATCAGgtcagtggccag........................ cccatccttcagGTTCAACATCGGTCCCCCCACATCCTCCATTCCCATCTTGTCCTCCTAC
K I M H T D A H 1 I D M R  F N I C C P T S S I P I L C S Y  1 0 8 1
CQ . I . V . . . . L . V . . . I  I .................................................................................S A
* 5  ~+--------------G L21-----------  - 1 *“
-C L 1 9 ---------- ► --------------- GX.11------ ►  ------------ C L12---------------  IV S 3
3 4 1 7  TTCTTTGATCAAGCCCCTCCACTTCTGCTGGACAAGATCTACAGCCCGCCTGATGACTCTGTCAGTGAACTCTGGACACACGCCCAGGTTGTAGgtacgtggagaa..................... t a t g t c
P  F F D E G P P V L L D K 1 Y S R P D D S V S E L W T H A Q V V  1 1 1 3
j J .  . ,  . | ^ . N .  . N N ......................................................L S . L E
3 5 1 1  ttccagCTCAACCCTATGGCTCCAAGAAGAGCATGGTCAIICTGACCAGCAGIGTCACCGCCGGCACCGCCGAGGAGTTCACCTATATCATGAAGAGGCTGGGCCGGGCCCIGCICATT 
f  G E R Y C S K K S M V I L T S S V T A C T A E E F T Y I M K R L C R A L V I  1 1 4 9J ...................................................................................................I L . * . A ..................................................................................................................
M ------------- GL7-------------
3 6 2 4  GCCGACGTGACCAGTCGGGGCTCCCAGCCACCACACACCTACCACGTGGATGACACCAACCTCTACCTCACTATCCCCACCCCCCCTTCTGTGGCGGCCTCGGATGGCACCTCCTGGGAA
C E V T S G G C e P P O T Y H V D D T N L y L t l P T A R S V G A S D G S S V E  1189
...................................................................» .............................J l l  • • • A ...................................................
----------------G L22-------- ►
3 7 4 4  CCCGTGCGGGTGACACCCCATGTCCTTGTCCCTCCAGAACAGCCTCTCGCCACGCCCAAGGAGATGCTCCACCACAACCACCTGACGCTGAAGCGGACCCCAGCCCTCCACGACCACCTC
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Fig. 2— continued
ATG. Minor alternate sites were located 6 bp upstream, and
7, 15, and 18 bp downstream of this site (Fig. 3). Three larger 
extension products of the Auall primer (upper part of lane 2 
in Fig. 3) are considered background for the following two 
reasons: 1) extensions with primers GL-1, GL-2, or GL-3 (Fig.
2) which prime upstream from GL-23 do not yield correspond­
ing extension products. 2) There are no bands of the same 
mobility in lane 1, the S i nuclease protection experiment. 
The mRNA sequence obtained when the primer extensions 
were carried out in the presence of dideoxynucleotides fol­
lowed precisely the gene sequence up to position +1 indicating 
the absence of introns in the 5'-flanking region (results not 
shown). No suitable “TATA” or “CAAT”-box sequences could 
be located within conventional distances (40) upstream from 
the transcriptional start sites (Fig. 2). Work is in progress in 
this laboratory to identify the IRBP promoter by its ability 
to express the bacterial chloramphenicol acetyltransferase 
gene in retinoblastoma cell lines.
Northern blot analysis of human retinal poly(A) mRNA 























Fig. 3. D eterm ination of the transcrip tion  s ta r t site in the 
IRBP gene. Lane 1 displays the products of SI nuclease digestion 
after hybridization of a 5' end-labeled 822-bp Ai>aII fragment of S3 
to 2 fig of human retina mRNA. Lane 2 displays the cDNA extension 
products generated by priming 2 ng of human retina mRNA with a 
synthetic, 21-nucleotide, antisense primer extending upstream from 
the AvaII site. At the left, labeled with GATC, is a sequence ladder 
generated by priming denatured S3 fragment with the same 21- 
nucleotide primer. The arrow indicates the major transcription start 
site (position +1). For more details, see text and “Experimental 
Procedures.” The sequencing gel contained 8% acrylamide. Exposure 
was for 72 h.
approximately 5200 bp (23). The distance between the tran­
scription start site and the polyadenylation signals located 
300 bp downstream from translational stop codon TAG is 
only 4400 bp (excluding introns). To account for the addi­
tional 800 bp, we assume the observed polyadenylation signals 
are followed by other signals further downstream. Large 3 '- 
untranslated sequences of 1700-2000 bp have been previously 
observed in bovine IRBP mRNA (22) and bovine and human 
opsin mRNA (41).
Quadruplication of the IRBP Gene—The IRBP cDNA se­
quence was compared with DNA and protein sequences con­
tained in GenBank (release 56) and Protein Identification 
Resources (release 17) data banks. The comparison yielded 
no gene or cDNA sequences with significant similarity to 
IRBP. Dot matrix analysis (Fig. 4) of the IRBP mRNA with 
itself, however, strongly suggests that the gene arose by quad­
ruplication of an ancestral sequence of approximately 900 bp. 
The four gene segments reveal a high degree of similarity 
(Fig. 4) preserving several domains of the expressed protein 
(see below). Rat serum retinol-binding protein which has been 
shown to be the product of gene duplication shows a similar 
close relationship between the two segments. In serum retinol- 
binding proteins, exons correspond to discrete tertiary struc­
tural elements (42). In the IRBP gene, all intron junctions 
were found in the last quadruplicated segment. This arrange­
ment of introns generates one large exon containing the first 
three segments of IRBP and parts of the fourth, one exon 
containing the COOH-terminal sequences, and two small 
exons exclusively containing sequences of the fourth segment. 
It is difficult to comprehend that this arrangement of exon/ 
intron junctions reflects the borders of building blocks, as 
observed in rat serum retinol-binding protein (42), or in the 
retinal-binding protein rhodopsin (41), where intron positions 
coincide with membrane boundaries, but a final answer has 
to await more information about the tertiary structure of 
IRBP.
Primary Sequence of IRBP and Internal Homologies—The
x IOOO bp
Fig. 4. In ternal quadruplication of the IRBP gene sequence.
Dot matrix analysis (Microgenie release 5, Beckman Instruments) of 
the IRBP cDNA sequence with itself starting at the transcription 
start site and extending to the polyadenylation signal. The sequence 
used for analysis is the composite gene and cDNA sequence of Fig. 2 
in which the introns were manually spliced out. The parameters were 
set at a window of 30 nucleotides with 60% stringency, or a dot was 
scored when 18 of 30 residues matched. The position of exon/intron 
junctions are indicated by arrows.
first translation initiation codon, ATG, was detected 122 bp 
downstream from the transcription start site, followed by a 
coding sequence of 3741 bp. No in-frame stop codon was 
found between transcriptional and translational start. The 
NH2 terminus of mature IRBP is defined as Gly at amino 
acid position 1, consistent with the peptide sequence 
GPTHLFQPSL found in mature human (12) and rhesus 
monkey IRBP (43). The 17-amino acid signal peptide preced­
ing the mature NH2 terminus glycine is rich in hydrophobic 
residues and ends in an alanine which is most commonly 
found at this position (44). The predicted mature human 
IRBP peptide has a calculated molecular weight of 133,000, 
significantly smaller than calculated for bovine IRBP 
(145,000), and in approximate agreement with the observed 
sodium dodecyl sulfate-gel mobility of 135,000 (12).
Tryptic COOH-terminal peptide sequences (Fig. 2) of bo­
vine IRBP (22, 23) and partial amino acid sequences derived 
from bovine cDNA clones were approximately 85% homolo­
gous to the human sequence. The COOH terminus itself has 
not been determined by peptide sequencing. The gene and 
cDNA sequences predicted a COOH-terminal sequence of 17 
residues, counted from the end of segment 4, or about 30 
residues shorter than the bovine IRBP sequence. This trun­
cated COOH terminus in human IRBP accounts for part of 
the difference in molecular weight to its bovine counterpart.
As indicated by the quadruplication of the gene sequence 
(Fig. 4), analysis of the primary sequence of IRBP reveals 
that this protein consists of four homologous segments of 
approximately equal length. An alignment of the four seg­
ments is shown in Fig. 5. For optimal alignment, several gaps 
had to be introduced. Of the amino acids aligned, up to 36% 
were identical. The similarity increased to approximately 60% 
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Fig. 5. Com parison of the four repeated segments of hum an IRBP. A, simplified diagram of the primary 
structure of IRBP. The numbers denote the last amino acid of each segment. Positions of putative A/ linked 
glycosylation sites in segment I and II are marked with a branched structure. Proline-rich regions in all four 
segments are indicated by a boxed P. Areas with homology to rhodopsin are dotted. B, alignment of the four 
segments of IRBP. Domains containing identical or similar residues (“conservative substitutions”) are boxed. The 
following residues are considered conservative substitutions (52): I = L = V = M ;D  = E ;H  = R = K ;S  = T. The 
putative glycosylation sites, N-X-T, in segments I and II are double underlined. Sequences with similarities to 
rhodopsin at the end of segments I and III are underlined. The proline-rich region is boxed. The positions of 
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Fig. 6. Sequence sim ilarities betw een the retinal-b inding 
protein  rhodopsin and the in te rs titia l retinoid-binding protein 
IRBP. A, sequence (position 89-130) of transmembrane helices 2, 3, 
and their interconnecting loop of human opsin, aligned with a partial 
sequence of segments 1, 2 (position 273-315) of IRBP. B, 14 residues 
of opsin’s cytoplasmic loop connecting transmembrane helices 5 and 
6 (position 236-250), aligned with a short sequence of IRBP (position 
789-803.
phobicity plots (45) do not identify a-helical transmembrane 
domains, consistent with the existence of IRBP in the extra­
cellular interstitial matrix, and do not indicate extensive 
internal hydrophobic domains, consistent with another reti­
nol-binding protein, serum retinol-binding protein (see below) 
in which the retinol-binding site is formed by a /3-barrel core 
consisting of several antiparallel /3-strands (42). The charge 
distribution in IRBP appears to be uniform, with a large
excess of negatively charged glutamic and aspartic acid resi­
dues (144 acidic and 83 basic residues), in agreement with the 
acidic p i of the protein (7).
Bovine IRBP has five putative AT-linked glycosylation sites 
NXT(S) (46), a t least one of which must be glycosylated in 
the mature protein (47). The human sequence displays only 
two putative glycosylation sites, located in well-conserved 
domains in the central part of segments I and II (Fig. 5). Each 
of the four segments of human IRBP has a region rich in 
proline (Fig. 5), condensed to five adjacent prolines in segment 
III, and four adjacent prolines in segment 1 (interspersed with 
a Glu). The proline-rich structure in segment 3 is located near 
the center of the elongated molecule and may be responsible 
for formation of a “hinge” structure of IRBP as observed in 
electron microscopical studies (14).
Sequence Comparison and Local Homologies to Other Reti­
noid-binding Proteins—Mammalian serum and cellular reti­
noid-binding proteins, such as rat serum retinol-binding pro­
teins (42), rat cellular retinol and bovine retinal-binding 
proteins (48, 49) and chicken purpurin (50) have been well 
characterized. Serum retinol-binding proteins transport reti­
nol from the liver to various retinol-dependent tissues, and 
rat cellular retinol and bovine retinal-binding proteins may 
serve as carriers of retinoids between various intracellular 
locations. Purpurin is a chicken neuroretina adhesion and cell 
survival protein found in the chicken retina interphotorecep­






















50% sequence homology to human serum retinol-binding pro­
teins. Binding of retinoids to IRBP is approximately 10-100­
fold weaker than observed for cellular and serum retinol- 
binding proteins indicating tha t IRBP may have a function 
different and distinct from these proteins which bind retinol 
tighter and more specifically. There is no significant sequence 
similarity of IRBP with serum and cellular retinol-binding 
proteins, or with any other protein sequence deposited in the 
GenBank or Protein Identification Resources data banks. We 
noticed, however, two short segments with sequence similarity 
in rhodopsin, the photoreceptor molecule in rod outer seg­
ments and a retinal-binding protein, and IRBP (Fig. 6). First, 
the intradiscal (extracellular) loop connecting membrane- 
spanning helices 2 and 3 of rhodopsin and the COOH-terminal 
end of IRBPs segment I share 15 matching residues in a 41- 
residue long segment. The sequence of this loop in rhodopsin 
has been precisely conserved in all mammalian opsins, but its 
function is unknown. Second, eight matches in a 14-residue 
segment of the cytoplasmic loop 5/6 of opsin and the COOH- 
terminal segment of segment III have been found. Loop 5/6 
of rhodopsin has been implicated in ROS G-protein binding, 
and serine 240 in opsin is known to be phosphorylated by 
opsin kinase (for review, see Ref. 51). The significance of 
these similarities is not known.
Acknowledgments—We thank Drs. Joe G. Hollyfield, Robert E. 
Anderson, Alice Adler, and Peter Ho for critically reading this man­
uscript. Mary Champagne provided technical assistance in sequencing 
genomic DNA. We are indebted to Dr. Charlie Lawrence for searching 
the GenBank and the Protein Identification Resources.
Addendum—Since submission of this manuscript, a paper by
S.-L. Fong and C. D. B. Bridges entitled Internal Quadruplication in 
the Structure of Human IR B P Deduced from Its Cloned cDNA  has 
been published ((1988) J. Biol. Chem. 26 3 , 15330-15334). The au­
thors report a peptide of 1262 residues (M , 136,600), in contrast to 
our 1,230 residues (M , 133,000), for mature human IRBP, as deduced 
from overlapping cDNA clones. The discrepancy is in part due to 
their COOH-terminal peptide sequence which deviates from ours at 
position 1228-1233, and in addition is 29 amino acids longer than 
ours. The differences are caused by insertion of a C at position 3728 
and a G at position 3747 (Fig. 2 on p. 15332) resulting in a double 
frame-shift. Our sequence lacks both nucleotides, ending the open 
reading frame at the stop codon at position 3750-3752. Our sequence 
was obtained from the same cDNA clone (H18) described by Fong 
and Bridges and is in agreement on both strands with sequences 
obtained from a genomic fragment (S4). However, a COOH-terminal 
peptide sequence of human IRBP which would match either sequence 
is currently not available.
Another major discrepancy is a 28-residue peptide (position 982­
1010 in Fig. 2, p. 15332) which does not match our sequence. Our 
corresponding sequence is 3 amino acids shorter and is virtually 
identical (except for 2 residues) with a deduced partial bovine se­
quence published by Liou et al. (22) and a bovine IRBP sequence 
published by Borst et al. (53). The strong homology between our 
sequence and the bovine IRBP sequence in the region of interest adds 
weight to our sequence being correct. Other minor differences in the 
two IRBP sequences are Fong and Bridges’ position 448(R) versus 
Liou et al. (22) 448(W) and position 973(E) versus 973(Q).
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